Exogenous Testosterone (T) Alone or with Finasteride Increases Physical Performance, Grip Strength, and Lean Body Mass in Older Men with Low Serum T
The DOI matches its Crossref record; 47 of the 49 references it cites were found in a registry or an index.
Abstract
Testosterone (T) therapy in older men with low serum T levels increases lean body mass and decreases fat mass. These changes might improve physical performance and strength; however, it has not been established whether T therapy improves functional outcome in older men. Moreover, concerns exist about the impact of T therapy on the prostate in older men. The administration of finasteride (F), which partially blocks the conversion of T to the more potent androgen, dihydrotestosterone, attenuates the impact of T replacement on prostate size and prostate-specific antigen. We hypothesized that T replacement in older, hypogonadal men would improve physical function and that the addition of F to this regimen would continue to provide the T-induced improvements in physical performance, strength, and body composition. Seventy men with low serum T (<350 ng/dl), age 65 yr and older, were randomly assigned to receive one of three regimens for 36 months: 1) T enanthate, 200 mg im every 2 wk, with placebo pills daily (T-only); 2) T enanthate, 200 mg every 2 wk, with 5 mg F daily (T + F); or 3) placebo injections and pills (placebo). We obtained serial measurements of timed physical performance, grip strength, lower extremity strength, body composition (by dual-energy x-ray absorptiometry), fasting cholesterol profiles, and hormones. Fifty men completed the 36-month protocol. After 36 months, T therapy significantly improved performance in a timed functional test when compared with baseline and placebo [4.3 +/- 1.6% (mean +/- sem, T-only) and 3.8 +/- 1.0% (T + F) vs. -5.6 +/- 1.9% for placebo (P < 0.002 for both T and T + F vs. placebo)] and increased handgrip strength compared with baseline and placebo (P < 0.05). T therapy increased lean body mass [3.77 +/- 0.55 kg (T-only) and 3.64 +/- 0.56 kg (T + F) vs. -0.21 +/- 0.55 kg for placebo (P < 0.0001)], decreased fat mass, and significantly decreased total cholesterol, low-density lipoprotein, and leptin, without affecting high-density lipoprotein, adiponectin, or fasting insulin levels. These results demonstrate that T therapy in older men with low serum T improves physical performance and strength over 36 months, when administered alone or when combined with F, and suggest that high serum levels of dihydrotestosterone are not essential for these beneficial effects of T in men.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Elsewhere, testosterone-associated increases in lean mass were accompanied by improvements in handgrip strength, knee extension and leg press and chest press exercises415,416.”
From Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies (2018) · cites this paper as [416]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Increasing serum testosterone levels to low- to mid-normal ranges through the administration of testosterone for several months in healthy older men resulted in increased muscle strength (133–136) and improved physical performance (134, 135).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [134]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Upon testosterone administration there is a decrease in fat mass and an increase in lean body mass and the net result is often, but not always, that total body weight does not show major changes.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [17]
In the citing paper
“Most randomized, placebo-controlled trials have indicated that T treatment increases lean mass and reduces fat mass in men with low serum T [2–7]”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [4]
In the citing paper
“but the overall effect on body weight and BMI in men with different T-status is inconsistent.”
From Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis (2017) · cites this paper as [4]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Plasma Concentrations of a Novel, Adipose-Specific Protein, Adiponectin, in Type 2 Diabetic Patients
Hotta, K., Funahashi, T., Arita, Y., Takahashi, M., Matsuda, M., Okamoto, Y., Iwahashi, H., Kuriyama, H., Ouchi, N., Maeda, K., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.6.1595 · Cited by 3,133 · cited 1×
“High levels of adiponectin have been suggested to be cardioprotective (44) and are associated with increased insulin sensitivity (45).”
BackgroundLongitudinal Effects of Aging on Serum Total and Free Testosterone Levels in Healthy Men
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J., & Blackman, M. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.2.7219 · Cited by 2,760
Feldman, H. A., Longcope, C., Derby, C. A., Johannes, C. B., Araujo, A. B., Coviello, A. D., Bremner, W. J., & McKinlay, J. B. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8201 · Cited by 1,861
Self-citationPlasma Adiponectin Levels and Risk of Myocardial Infarction in Men
Pischon, T. (2004) · JAMA · doi:10.1001/jama.291.14.1730 · Cited by 1,773
Esposito, K., Pontillo, A., Di Palo, C., Giugliano, G., Masella, M., Marfella, R., & Giugliano, D. (2003) · JAMA · doi:10.1001/jama.289.14.1799 · Cited by 1,511
Cnop, M., Havel, P. J., Utzschneider, K. M., Carr, D. B., Sinha, M. K., Boyko, E. J., Retzlaff, B. M., Knopp, R. H., Brunzell, J. D., & Kahn, S. E. (2003) · Diabetologia · doi:10.1007/s00125-003-1074-z · Cited by 1,483 · cited 1×
“In cross-sectional analyses, adiponectin seems to be inversely correlated with FM (40, 41), and levels have been shown to increase with weight loss in normal subjects (42, 43).”
BackgroundYang, W.-S., Lee, W.-J., Funahashi, T., Tanaka, S., Matsuzawa, Y., Chao, C.-L., Chen, C.-L., Tai, T.-Y., & Chuang, L.-M. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.8.3815 · Cited by 1,181 · cited 1×
“In cross-sectional analyses, adiponectin seems to be inversely correlated with FM (40, 41), and levels have been shown to increase with weight loss in normal subjects (42, 43).”
BackgroundMuscle strength and speed of movement in relation to age and muscle morphology
Larsson, L., Grimby, G., & Karlsson, J. (1979) · Journal of Applied Physiology · doi:10.1152/jappl.1979.46.3.451 · Cited by 1,135
A cross-sectional study of muscle strength and mass in 45- to 78-yr-old men and women
Frontera, W. R., Hughes, V. A., Lutz, K. J., & Evans, W. J. (1991) · Journal of Applied Physiology · doi:10.1152/jappl.1991.71.2.644 · Cited by 1,011
Testosterone dose-response relationships in healthy young men
Bhasin, S., Woodhouse, L., Casaburi, R., Singh, A. B., Bhasin, D., Berman, N., Chen, X., Yarasheski, K. E., Magliano, L., Dzekov, C., et al. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1172 · Cited by 967 · cited 1×
“Such changes in body composition are likely due to increases in muscle mass, as has been reported in younger men receiving T (33).”
Result
Cited by
Items 201–300 of 576
Examining the association between grip strength and testosterone
Chiu, H.-T., Shih, M.-T., & Chen, W. (2019) · The Aging Male · doi:10.1080/13685538.2019.1632282 · Cited by 55
“Recently, many surveys have indicated that declining muscle mass, muscle strength, disability, and reduced physical performance have a significant positive relationship with testosterone deficiency, and the correlation between grip strength and decreasing serum total testosterone has been recognized using only freely…”
BackgroundKapoor, D., & Jones, T. H. (2008) · Drugs & Aging · doi:10.2165/00002512-200825050-00001 · Cited by 57
Strength and multimorbidity among community-dwelling elderly from southern Brazil
Montes, M. C., Bortolotto, C. C., Tomasi, E., González, M. C., Barbosa-Silva, T. G., Domingues, M. R., & Bielemann, R. M. (2019) · Nutrition · doi:10.1016/j.nut.2019.110636 · Cited by 56
Bogaert, V., Taes, Y., Konings, P., Van Steen, K., De Bacquer, D., Goemaere, S., Zmierczak, H., Crabbe, P., & Kaufman, J. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03173.x · Cited by 50
Is Testosterone Replacement Therapy in Older Men Effective and Safe?
Yabluchanskiy, A., & Tsitouras, P. D. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00716-2 · Cited by 53
An update on male hypogonadism therapy
Surampudi, P., Swerdloff, R. S., & Wang, C. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.913022 · Cited by 45
“While the significant weight loss requires careful confirmation, randomized controlled trials showed that testosterone replacement therapy reduced body fat mass, regional fat distribution and waist circumference in hypogonadal men with and without obesity [48,53-61].”
Barbosa-Desongles, A., Hernández, C., Simó, R., & Selva, D. M. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00019.2013 · Cited by 49
Partial Androgen Deficiency, Depression, and Testosterone Supplementation in Aging Men
Amore, M., Innamorati, M., Costi, S., Sher, L., Girardi, P., & Pompili, M. (2012) · International Journal of Endocrinology · doi:10.1155/2012/280724 · Cited by 55
Frailty and Muscle Function: Role for Testosterone?
Srinivas-Shankar, U., & Wu, F. C. W. (2008) · Frontiers of Hormone Research · doi:10.1159/000176050 · Cited by 45
Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency
Traish, A. M. (2017) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2017.10.001 · Cited by 48
Chen, X., Li, C., Chen, Y., Xi, H., Zhao, S., Ma, L., Xu, Z., Zhao, H., Zhao, J., Ge, R., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1461-0 · Cited by 46
Tallis, J., Shelley, S., Degens, H., & Hill, C. (2021) · Biomolecules · doi:10.3390/biom11030372 · Cited by 41
Bouloux, P. M. G., Legros, J.-J., Elbers, J. M. H., Geurts, T. B. P., Kaspers, M. J. G. H., Meehan, A. G., Meuleman, E. J. H., & and for the Study 43203 Investigators (2013) · The Aging Male · doi:10.3109/13685538.2013.773420 · Cited by 46
“The increase of LBM in our study was also similar to that reported in aging, hypogonadal men treated with testosterone patches for 6–36 months [3,4,9,23], but less than observed after treatment for 6 months with testosterone ester injections of 125 mg/week or higher [7].”
ResultTestosterone replacement therapy for older men
Borst, S. E., & Mulligan, T. (2008) · Clinical Interventions in Aging · doi:10.2147/cia.s1609 · Cited by 59
“First, while replacement doses of testosterone do not consistently produce substantial increases in strength, Page et al (2005) and Bhasin et al (2005) have shown that higher doses of testosterone do produce such increases.”
George, A., & Henkel, R. (2014) · Andrologia · doi:10.1111/and.12214 · Cited by 54
Men's Faces Convey Information about their Bodies and their Behavior: What you see is what you get
Shoup-Knox, M. L., & Gallup, G. G. (2008) · Evolutionary Psychology · doi:10.1177/147470490800600311 · Cited by 45
“This is particularly interesting in light of evidence showing that handgrip strength is correlated with serum testosterone levels (Page et al., 2005).”
BackgroundPermpongkosol, S., Tantirangsee, N., & Ratana-olarn, K. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01994.x · Cited by 45
Wu, H., Yu, B., Meng, G., Liu, F., Guo, Q., Wang, J., Du, H., Zhang, W., Shen, S., Han, P., et al. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4522 · Cited by 47
“Furthermore, because levels of sex hormones such as testosterone and estrogen play a key role in muscle development, and higher levels of androgenic hormones in men might account for the sex difference in muscle mass and handgrip (Page et al., 2005).”
BackgroundCoviello, A. D., Lakshman, K., Mazer, N. A., & Bhasin, S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0822 · Cited by 44
Androgen deficiency: effects on body composition
Miller, K. K. (2008) · Pituitary · doi:10.1007/s11102-008-0121-7 · Cited by 49
“Despite negative results in three [28, 34, 35] of the four placebo-controlled studies [26, 28, 34, 35] that examined grip strength, the metaanalysis demonstrated an overall positive effect of testosterone [22].”
ResultReyes-Vallejo, L., Lazarou, S., & Morgentaler, A. (2007) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2006.00381.x · Cited by 43
Testosterone Replacement, Muscle Strength, and Physical Function
Nam, Y., Lee, G., Yun, J. M., & Cho, B. (2018) · The World Journal of Men s Health · doi:10.5534/wjmh.182001 · Cited by 44
“The other primary and secondary outcomes investigated in each of the studies are listed in Table 1 [2,7-9,14-27].”
BackgroundInfluentialTestosterone Deficiency and Replacement in Older Men
Bremner, W. J. (2010) · New England Journal of Medicine · doi:10.1056/nejme1006197 · Cited by 41
Self-citationPartial androgen deficiency, depression and testosterone treatment in aging men
Amore, M., Scarlatti, F., Quarta, A. L., & Tagariello, P. (2009) · Aging Clinical and Experimental Research · doi:10.1007/bf03324891 · Cited by 45
Intracrine and Myotrophic Roles of 5α-Reductase and Androgens: A Review
YARROW, J. F., MCCOY, S. C., & BORST, S. E. (2012) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31823bfcbf · Cited by 38
Do androgens play any role in the physical frailty of ageing men?
O’Connell, M. D. L., Tajar, A., Roberts, S. A., & Wu, F. C. W. (2010) · International Journal of Andrology · doi:10.1111/j.1365-2605.2010.01093.x · Cited by 49
Vandenput, L., Mellström, D., Laughlin, G. A., Cawthon, P. M., Cauley, J. A., Hoffman, A. R., Karlsson, M. K., Rosengren, B. E., Ljunggren, Ö., Nethander, M., et al. (2017) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.3088 · Cited by 40
Chasland, L. C., Yeap, B. B., Maiorana, A., Chan, Y. X., Maslen, B. A., Cooke, B. R., Dembo, L. G., Naylor, L. H., & GREEN, D. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00010.2021 · Cited by 46
Testosterone undecanoate in the treatment of male hypogonadism
Edelstein, D. L., & Basaria, S. S. (2010) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2010.505920 · Cited by 44
“This finding is in contrast to previous studies that have shown an increase in plasma DHT levels upon administration of testosterone [16,17,23].”
ResultOtzel, D. M., Lee, J., Ye, F., Borst, S. E., & Yarrow, J. F. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061701 · Cited by 43
Nian, Y., Ding, M., Hu, S., He, H., Cheng, S., Yi, L., Li, Y., & Wang, Y. (2017) · Andrologia · doi:10.1111/and.12630 · Cited by 35
“As Page et al.(2005) showed in their work, TRT in older men with low serum testosterone levels increases lean body mass, decreases fat mass and improves physical performance and strength, but other trials that evaluated physical function by muscle strength and body composition reported that TRT has…”
BackgroundValidated treatments and therapeutics prospectives regarding pharmacological products for sarcopenia
Onder, G., Della Vedova, C., & Landi, F. (2009) · The Journal of nutrition, health and aging · doi:10.1007/s12603-009-0209-4 · Cited by 39
Bhasin, S., & Storer, T. W. (2008) · Frontiers of Hormone Research · doi:10.1159/000176052 · Cited by 37
Miner, M. M., & Seftel, A. D. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01317.x · Cited by 39
Cruz-Jentoft, A. J., Triana, F. M. C., Gómez‐Cabrera, M. C., López‐Soto, A., Masanés, F., Matía‐Martín, P., Rexach, J. A. S., Ruiz, D., Salvà, A., Viña, J., et al. (2011) · Revista Española de Geriatría y Gerontología · doi:10.1016/j.regg.2010.11.004 · Cited by 76
Liu, P. Y., Pincus, S. M., Takahashi, P. Y., Roebuck, P. D., Iranmanesh, A., Keenan, D. M., & Veldhuis, J. D. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00227.2005 · Cited by 38
Association of plasma sex hormone levels with functional decline in elderly men and women
Fukai, S., Akishita, M., Yamada, S., Hama, T., Ogawa, S., Iijima, K., Eto, M., Kozaki, K., Toba, K., & Ouchi, Y. (2009) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2009.00534.x · Cited by 39
Androgen therapy and atherosclerotic cardiovascular disease
McGrath, K. C. Y. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.11 · Cited by 45
“Similarly, small intervention trials have demonstrated that exogenous T supplementation in young men lowers HDL (Meriggiola et al 1995; Wu et al 1996) but in older men T did not affect HDL (Snyder et al 2001; Page et al 2005).”
BackgroundSchroeder, E. T., He, J., Yarasheski, K. E., Binder, E. F., Castaneda-Sceppa, C., Bhasin, S., Dieli-Conwright, C. M., Kawakubo, M., Roubenoff, R., Azen, S. P., et al. (2012) · European Journal of Applied Physiology · doi:10.1007/s00421-011-2077-y · Cited by 37
“Limited data support the potential value of treatment with replacement doses of testosterone to improve lean mass in older persons (Orwoll et al. 2006; Page et al. 2005).”
Bhasin, S., Krishnan, V., Storer, T. W., Steiner, M., & Dobs, A. S. (2023) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glad027 · Cited by 36
Testosterone Replacement Therapy in Hypogonadal Men: Assessing Benefits, Risks, and Best Practices
Miner, M. M., Canty, D. J., & Shabsigh, R. (2008) · Postgraduate Medicine · doi:10.3810/pgm.2008.09.1914 · Cited by 36
Petersson, S. J., Christensen, L. L., Kristensen, J. M., Kruse, R., Andersen, M., & Højlund, K. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0006 · Cited by 35
Ebeling, P. R. (2010) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328339658c · Cited by 38
LeBrasseur, N. K., Lajevardi, N., Miciek, R., Mazer, N., Storer, T. W., & Bhasin, S. (2009) · Contemporary Clinical Trials · doi:10.1016/j.cct.2008.10.005 · Cited by 34
Osteoporosis in Men: Epidemiology, Pathophysiology, and Clinical Characterization
ORWOLL, E. S., & KLEIN, R. F. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50044-6 · Cited by 36
The Impact of Drug Reimbursement Policy on Rates of Testosterone Replacement Therapy among Older Men
Piszczek, J., Mamdani, M., Antoniou, T., Juurlink, D. N., & Gomes, T. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098003 · Cited by 35
Diago-Galmés, A., Guillamón-Escudero, C., Tenías, J. M., Soriano, J. M., & Garrido, J. F. (2021) · Biology · doi:10.3390/biology10020093 · Cited by 35
“An inverse situation to that is found in the available bibliography [54,63,64].”
BackgroundAdding Challenge to Performance-Based Tests of Walking: The Walking InCHIANTI Toolkit (WIT)
Bandinelli, S., Pozzi, M., Lauretani, F., Phillips, C. L., Shumway‐Cook, A., Guralnik, J. M., & Ferrucci, L. (2006) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/01.phm.0000233210.69400.d4 · Cited by 37
Hong, D., Kim, Y., Son, E. S., Kim, K.-N., Kim, B.-T., Lee, D.-J., & Kim, K.-M. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.10.016 · Cited by 35
Review of health risks of low testosterone and testosterone administration
Jia, H., Sullivan, C. T., McCoy, S. C., Yarrow, J. F., Morrow, M., & Borst, S. E. (2015) · World Journal of Clinical Cases · doi:10.12998/wjcc.v3.i4.338 · Cited by 36
Crawford, K. W., Li, X., Xu, X., Abraham, A. G., Dobs, A. S., Margolick, J. B., Palella, F. J., Kingsley, L., Witt, M. D., & Brown, T. T. (2013) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2013.0020 · Cited by 36
Metabolic syndrome and hypogonadism – two peas in a pod
Ebrahimi, F., & Christ‐Crain, M. (2016) · Swiss Medical Weekly · doi:10.4414/smw.2016.14283 · Cited by 36
The Metabolic Syndrome in Central Hypogonadotrophic Hypogonadism
Dwyer, A. A., & Quinton, R. (2018) · Frontiers of hormone research · doi:10.1159/000485998 · Cited by 32
Hamann, L. G., Manfredi, M. C., Sun, C., Krystek, S. R., Huang, Y., Bi, Y., Augeri, D. J., Wang, T., Zou, Y., Betebenner, D. A., et al. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.01.076 · Cited by 35
Page, S. T., Hirano, L. A., Gilchriest, J., Dighe, M., Amory, J. K., Marck, B. T., & Matsumoto, A. M. (2011) · The Journal of Urology · doi:10.1016/j.juro.2011.03.026 · Cited by 32
Self-citationHong, S. K., Min, G. E., Ha, S. B., Doo, S. H., Kang, M., Park, H. J., Yoon, C. Y., Jeong, S. J., Byun, S., & Lee, S. E. (2010) · British Journal of Urology · doi:10.1111/j.1464-410x.2009.08915.x · Cited by 34
Hernández, J. J. C., Almeida, M. D. G., Miralles, J. M., & Órfão, A. (2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.05.040 · Cited by 32
Androgen Deficiency in Aging and Metabolically Challenged Men
Shelton, J. B., & Rajfer, J. (2011) · Urologic Clinics of North America · doi:10.1016/j.ucl.2011.09.007 · Cited by 32
Deer, R., Dickinson, J. M., Baillargeon, J., Fisher, S. R., Raji, M. A., & Volpi, E. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz084 · Cited by 34
Carlson, N. E., Brenner, L. A., Wierman, M. E., Harrison-Felix, C., Morey, C., Gallagher, S., & Ripley, D. (2009) · Brain Injury · doi:10.1080/02699050902788535 · Cited by 30
Pharmaceutical Interventions for Frailty and Sarcopenia
Laosa, O., Alonso, C., Castro, M., & Rodríguez‐Mañas, L. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660705 · Cited by 33
Jin, S., Hu, Y., Fu, H., Jiang, S., Xiong, Y., Qiao, H., Zhang, W., Gong, Y., & Wu, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20163995 · Cited by 30
Page, S. T., Marck, B. T., Tolliver, J. M., & Matsumoto, A. M. (2007) · Endocrinology · doi:10.1210/en.2007-0956 · Cited by 33
Self-citationGREEN, D. J., Chasland, L. C., Yeap, B. B., & Naylor, L. H. (2024) · Sports Medicine - Open · doi:10.1186/s40798-024-00703-x · Cited by 34
“In contrast, other studies of T treatment alone (i.e. no exercise intervention) have reported improvements in strength [35, 48, 52, 57, 59, 98, 114, 115].”
ResultTestosterone replacement in men
Beg, S., Al-Khoury, L., & Cunningham, G. R. (2008) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0b013e328305081a · Cited by 30
Androgen deficiency and type 2 diabetes mellitus
Gibb, F. W., & Strachan, M. W. J. (2014) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2014.04.004 · Cited by 31
Goncharov, N. P., Katsya, G. V., Chagina, N. A., & Gooren, L. J. (2008) · The Aging Male · doi:10.1080/13685530802204629 · Cited by 29
“The combination of low plasma T and SHBG and metabolic syndrome has been repeatedly reported in the literature [10,11,14,20,21].”
BackgroundAndrogens and male aging: current evidence of safety and efficacy
Gooren, L. J. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.4 · Cited by 30
Physiological basis behind ergogenic effects of anabolic androgens
Cheung, A. S., & Grossmann, M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.01.047 · Cited by 33
Morley, J. E. (2010) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2010.07.008 · Cited by 29
Testosterone Treatment in Middle-Aged and Older Men with Hypogonadism
Bhasin, S., & Snyder, P. J. (2025) · New England Journal of Medicine · doi:10.1056/nejmra2404637 · Cited by 31
Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights
Bhasin, S., Wang, C., Chandra, M. R. G., Gagliano‐Jucá, T., & Jasuja, R. (2025) · Endocrine Reviews · doi:10.1210/endrev/bnaf041 · Cited by 32
Aguirre, L. E., Jan, I. Z., Fowler, K., Waters, D. L., Villareal, D. T., & Armamento‐Villareal, R. (2014) · International Journal of Endocrinology · doi:10.1155/2014/507395 · Cited by 31
“Moreover, testosterone replacement has been shown to improve physical function in healthy and mostly frail elderly men, as assessed by physical performance test [27], timed physical function test [25], aggregate locomotor function [27], and loaded stair-climbing [26].”
BackgroundMethodTestosterone therapy in men with testosterone deficiency: Are we beyond the point of no return?
Traish, A. M. (2016) · Korean journal of urology · doi:10.4111/icu.2016.57.6.384 · Cited by 33
“A number of interventional and observational studies have demonstrated consistently that T therapy improves body composition and contributes to increased LBM and reduced FM [42-44,50,52,73-77].”
BackgroundKruse, R., Petersson, S. J., Christensen, L. L., Kristensen, J. M., Sabaratnam, R., Ørtenblad, N., Andersen, M., & Højlund, K. (2020) · Metabolism · doi:10.1016/j.metabol.2020.154347 · Cited by 29
Developing Interventions for Frailty
Cameron, I. D., Fairhall, N., Gill, L., Lockwood, K., Langron, C., Aggar, C., Monaghan, N., & Kurrle, S. E. (2015) · Advances in Geriatrics · doi:10.1155/2015/845356 · Cited by 34
“[29] S.”
Hormones and health outcomes in aging men
Yeap, B. B. (2012) · Experimental Gerontology · doi:10.1016/j.exger.2012.07.012 · Cited by 30
Should frailty be treated with testosterone?
Morley, J. E. (2010) · The Aging Male · doi:10.3109/13685538.2010.502271 · Cited by 28
“Testosterone was also shown to improve physical performance when administered over a 3-year period [38].”
BackgroundMünzer, T., Harman, S. M., Sorkin, J. D., & Blackman, M. R. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1275 · Cited by 34
Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II
Traish, A. M. (2014) · Steroids · doi:10.1016/j.steroids.2014.05.004 · Cited by 29
Dihydrotestosterone is elevated following sprint exercise in healthy young men
Smith, A. A., Toone, R. J., Peacock, O. J., Drawer, S., Stokes, K., & Cook, C. J. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01419.2012 · Cited by 30
Testosterone replacement therapy and the risk of prostate cancer. Is there a link?
Barqawi, A. B., & Crawford, E. D. (2005) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3901418 · Cited by 29
Hand Grip Strength and Self-Perceptions of Physical Attractiveness and Psychological Well-Being
Sneade, M., & Furnham, A. F. (2016) · Evolutionary Psychological Science · doi:10.1007/s40806-016-0042-z · Cited by 28
“HGS has thus been shown to be related to reproductive success, dominant behavior, physical performance, and sexual function (Atkinson et al. 2012; Gallup et al. 2009; Page et al. 2005).”
BackgroundHernández-Martínez, J., Pérez-Cárcamo, J., Coñapi-Union, B., Canales-Canales, S., Negron-Molina, M., Avila-Valencia, S., Cid-Calfucura, I., Herrera-Valenzuela, T., Cisterna, D., Branco, B. H. M., et al. (2024) · Applied Sciences · doi:10.3390/app14209165 · Cited by 29
Revista Española de Geriatría y Gerontología
Santos, R. P., Torres, C. F., Martín‐Arranz, M. D., de Parga, J. M. S., & Martínez, M. A. (2016) · Cited by 26
Jang, I., Jung, H., Lee, C. K., Jang, K. H., Cho, E.-I., Jung, J. J., Park, E.-A., Kim, J., Lee, Y. S., Lee, E., et al. (2017) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13017 · Cited by 26
The diagnosis of late life hypogonadism
Morley, J. E. (2007) · The Aging Male · doi:10.1080/13685530701695463 · Cited by 26
“In addition, a well conducted three year study showed that testosterone increased function in older men [55].”
BackgroundAdvances in male hormone substitution therapy
Qoubaitary, A., Swerdloff, R. S., & Wang, C. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.9.1493 · Cited by 26
“In older men, assessment of muscle strength is more difficult [1,76,77,79,80] and improvement in strength has not always been demonstrated.”
BackgroundMisra, M., Katzman, D. K., Cord, J., Manning, S. J., Mickley, D. W., Herzog, D. B., Miller, K. K., & Klibanski, A. (2008) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26273 · Cited by 25
Kolovou, G. D., Bilianou, H. I., Marvaki, A., & Mikhailidis, D. P. (2010) · American Journal of Men s Health · doi:10.1177/1557988310370360 · Cited by 27
“Studies of short duration (Bakhshi, Elliott, Gentili, Godschalk, & Mulligan, 2000; Carruthers, 2009; Morley & Perry, 2003; Page et al., 2005) and longer duration (Morley et al., 1997; Sih et al., 1997; Snyder et al., 1999) reported that testosterone administration to elderly men with low levels of…”
BackgroundCunningham, G. R. (2013) · Endocrine Practice · doi:10.4158/ep13217.ra · Cited by 28
Sex-associated autosomal DNA methylation differences are wide-spread and stable throughout childhoodPreprint
Suderman, M. J., Simpkin, A. J., Sharp, G. C., Gaunt, T. R., Lyttleton, O., McArdle, W. L., Ring, S. M., Smith, G. D., & Relton, C. L. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/118265 · Cited by 25
“(71)) and can be improved by testosterone 350 therapy in men with low testosterone levels (72, 73).”
BackgroundFrailty and testosterone level in older adults: a systematic review and meta-analysis
Peng, X., Hou, L., Zhao, Y., Lin, T., Wang, H., Gao, L., & Yue, J. (2022) · European Geriatric Medicine · doi:10.1007/s41999-022-00614-8 · Cited by 24
Testosterone Replacement Therapy: A Narrative Review with a Focus on New Oral Formulations
Bhat, S. Z., & Dobs, A. S. (2022) · touchREVIEWS in Endocrinology · doi:10.17925/ee.2022.18.2.133 · Cited by 25
To Defer or to Stand up? How Offender Formidability Affects Third Party Moral Outrage
Jensen, N. H., & Petersen, M. B. (2011) · Evolutionary Psychology · doi:10.1177/147470491100900113 · Cited by 28
“As testosterone is both the main determinant of physical strength (lean muscle mass) (Griggs et al., 1989; Lassek and Gaulin, 2009; Page et al., 2005) and of sexual dimorphism of the face (Penton-Voak and Chen, 2004; Pound, Penton-Voak, and Surridge, 2009; Weston, Friday, and Lio, 2007), it has…”
BackgroundScientific overview of hormone treatment used for rejuvenation
Morley, J. E. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.04.009 · Cited by 24
Digit Ratio (2D:4D) and Handgrip Strength in Hani Ethnicity
Zhao, D., Yu, K., Zhang, X., & Lianbin, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0077958 · Cited by 31
Holland, A. M., Roberts, M. D., Mumford, P. W., Mobley, C. B., Kephart, W. C., Conover, C. F., Beggs, L. A., Balaez, A., Otzel, D. M., Yarrow, J. F., et al. (2016) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00238.2016 · Cited by 26
“Interestingly, testosterone administration is known to improve subcutaneous and visceral adiposity and the associated morbidities known as metabolic syndrome (7, 9, 15, 18, 19, 28, 42, 55, 57, 58), exerting its effects on fat directly via AR binding and indirectly after tissue-specific aromatase enzyme conversion of t…”
BackgroundTestosterone, frailty and physical function in older men
Hsu, B., Cumming, R. G., & Handelsman, D. J. (2018) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2018.1475227 · Cited by 25
“Another trial of 70 men aged 65 and older on T therapy for 3 years found that there was a positive effect on physical performance tests and handgrip strength, but not in any of the lower extremity muscle strength measures [74].”
BackgroundPage, S. T., Kupelian, V. A., Bremner, W. J., & McKinlay, J. B. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02598.x · Cited by 26
Self-citation
Metadata
- Authors
- Page, S. T., Amory, J. K., Bowman, F. D., Anawalt, B. D., Matsumoto, A. M., Bremner, W. J., & Tenover, J. L.
- Affiliations
- Emory University (US)
- VA Puget Sound Health Care System (US)
- University of Washington (US)
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-03
- Volume
- 90
- Issue
- 3
- Pages
- 1502-1510
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2116827517
- Cited by
- 566
- References
- 49
- Citations by year
- 2026: 4 · 2025: 12 · 2024: 10 · 2023: 14 · 2022: 20 · 2021: 12 · 2020: 16 · 2019: 26 · 2018: 30 · 2017: 31 · 2016: 29 · 2015: 22 · 2014: 34 · 2013: 24 · 2012: 34
- FWCI
- 25.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- ResearchWorks at the University of Washington (University of Washington) (submittedVersion)
- Funders
- National Institutes of Health (5r01ag010975-04, HL007028)
- National Institute on Aging (K23AG027238, AG10975)
- National Heart, Lung, and Blood Institute (HL-007028, T32HL007028)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Keywords
- testosterone replacement therapy, finasteride, hypogonadism, older men, physical performance, grip strength, lean body mass, body composition, testosterone enanthate, prostate-specific antigen, cholesterol, leptin, functional performance, lower limb strength
- MeSH terms
- Aged, Aged, 80 and over, Aging, Androgens, Body Composition, Double-Blind Method, Drug Therapy, Combination, Enzyme Inhibitors, Humans, Hypogonadism, Insulin, Lipids, Male, Motor Activity, Testosterone, Body Mass Index, Finasteride, Hand Strength, Leptin, Intercellular Signaling Peptides and Proteins, Adiponectin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.